The way over-the-counter drugs are regulated is a mess — and Congress is ready to step in
(By Erin Mershon for STAT) WASHINGTON — The Food and Drug Administration has, for years, limited the amount of acetaminophen
Read More
Legislative Update
8 things to know about CHIP funding right now
(By Emily Rappleye for Becker’s Hospital Review) Funding for the Children’s Health Insurance Program ran out in September, putting coverage
Read MoreLawmakers introduce stronger data breach notification law
(By Julie Spitzer for Becker’s Hospital Review) Amid the massive Uber data breach in which company officials paid hackers $100,000
Read MoreThe Beneficiary Enrollment Notification and Eligibility Simplification Act
According to the Congressional Research Service, 750,000 Medicare beneficiaries get socked with a Medicare Part B late-enrollment penalty in 2014.
Read MoreAlex Azar’s 4 biggest priorities as HHS secretary
(By Leo Vartorella for Becker’s Hospital Review) Alex Azar, President Donald Trump’s nominee for HHS secretary, appeared before the Senate Health, Education,
Read MoreCongressional inaction threatens states’ CHIP funding: 5 things to know
(By Kelly Gooch for Becker’s Hospital Review) States are bracing to potentially lose Children’s Health Insurance Program funding amid federal
Read MoreHeated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program
(By Sarah Jane Tribble for Kaiser Health News) A 25-year-old federal drug discount program has grown so big and controversial
Read MoreHouse reaches bipartisan agreement on Medicare extenders
(By Emily Rappleye for Becker’s Hospital Review) The House Ways and Means Committee reached a bipartisan agreement Wednesday to authorize funding for
Read MoreMaine Voters Greenlight Medicaid Expansion, But Governor Says Whoa
(By Patty Wight, Maine Public for Kaiser Health News) Just hours after Maine voters became the first in the nation
Read MoreTrump takes on hospitals: the facts behind fight over 340B drug discounts
(By Casey Ross for STAT) There’s at least one unassailable fact in the battle over the federal 340B drug discount
Read More